外泌体在消化系统恶性肿瘤检测中的应用进展
Advances in Exosomes in the Detection of Malignant Tumors of the Digestive System
DOI: 10.12677/ACM.2022.12111465, PDF,    国家自然科学基金支持
作者: 武文璇, 王 坤, 张贺秋*:滨州医学院,山东 烟台;付 强*:滨州医学院,山东 烟台;山东思乐基医药科技有限公司,山东 烟台;北卡罗莱纳大学Lineberger肿瘤中心,美国 教堂山
关键词: 外泌体应用检测肿瘤miRNAExosome Application Detection Tumors miRNA
摘要: 外泌体是由哺乳动物细胞释放的纳米级双层囊泡小体,曾经一度被认为是身体中的垃圾箱,然而随着对其研究的不断深入,现在被认为是细胞间的通讯介质,能参与机体多种生理和病理过程。最近几年从肿瘤外泌体中寻找特异性的标志物成为了肿瘤研究者重点关注的方向,对肿瘤早期的诊断、疗效的评价和预后的分析具有重要意义。消化系统肿瘤一直是大家比较关注的疾病,常见的恶性肿瘤有:食管癌、胃癌、胰腺癌、肝细胞癌、结直肠癌等,文章主要综述了外泌体及外泌体内含蛋白质和miRNA的功能在这几种常见的消化系统恶性肿瘤检测中的应用进展。
Abstract: Exosomes are nanoscale bilayer vesicle bodies released by mammalian cells once thought to be dustbins, are now thought to be communication mediators between cells which can participate in a variety of physiological and pathological processes. In recent years, the search for specific markers from tumor exosomes has become the focus of tumor researchers, which is of great significance for the early diagnosis, efficacy evaluation and prognosis analysis of tumors. Tumor of digestive system has always been a disease of great concern. Common malignant tumors include esophagus cancer, gastric cancer, pancreatic cancer, hepatocellular carcinoma, colorectal cancer, etc. This paper main-ly reviewed the application progress of exosomes and functions of exosomes containing proteins and miRNAs in the diagnosis of these three common malignant tumors of digestive system.
文章引用:武文璇, 王坤, 张贺秋, 付强. 外泌体在消化系统恶性肿瘤检测中的应用进展[J]. 临床医学进展, 2022, 12(11): 10161-10167. https://doi.org/10.12677/ACM.2022.12111465

参考文献

[1] Fu, M., Gu, J., Jiang, P., et al. (2019) Exosomes in Gastric Cancer: Roles, Mechanisms, and Applications. Molecular Cancer, 18, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[2] Kalluri, R. and LeBleu, V.S. (2020) The Biology, Function, and Biomedical Applications of Exosomes. Science, 367, eaau6977. [Google Scholar] [CrossRef] [PubMed]
[3] Huang, J., Shen, M., Yan, M., et al. (2019) Exosome-Mediated Transfer of miR-1290 Promotes Cell Proliferation and Invasion in Gastric Cancer via NKD1. Acta Biochimica et Bio-physica Sinica, 51, 900-907. [Google Scholar] [CrossRef] [PubMed]
[4] Wolfers, J., Lozier, A., Raposo, G., et al. (2001) Tumor-Derived Exo-somes Are a Source of Shared Tumor Rejection Antigens for CTL Cross-Priming. Nature Medicine, 7, 297-303. [Google Scholar] [CrossRef] [PubMed]
[5] Avgeris, M., Panoutsopoulou, K. and Papadimitriou, M.A. (2019) Circulating Exosomal miRNAs: Clinical Significance in Human Cancers. Expert Review of Molecular Diagnostics, 19, 979-995. [Google Scholar] [CrossRef] [PubMed]
[6] Barile, L. (2017) Exosomes: Therapy Delivery Tools and Biomarkers of Diseases. Pharmacology & Therapeutics, 174, 63-78. [Google Scholar] [CrossRef] [PubMed]
[7] 鲁悦, 戴琪, 武鑫, 等. 外泌体的功能及其在肿瘤诊疗中的应用[J]. 药学服务与研究, 2019, 19(3): 172-174, 179.
[8] O’Brien, K., Breyne, K., Ughetto, S., Laurent, L.C. and Breakefield, X.O. (2020) RNA Delivery by Extracellular Vesicles in Mammalian Cells and Its Applications. Nature Re-views Molecular Cell Biology, 21, 585-606. [Google Scholar] [CrossRef] [PubMed]
[9] Ivey, K.N. and Srivastava, D. (2015) microRNAs as Develop-mental Regulators. Cold Spring Harbor Perspectives in Biology, 7, a008144. [Google Scholar] [CrossRef] [PubMed]
[10] Isaac, R., Reis, F.C.G., Ying, W. and Olefsky, J.M. (2021) Ex-osomes as Mediators of Intercellular Crosstalk in Metabolism. Cell Metabolism, 33, 1744-1762. [Google Scholar] [CrossRef] [PubMed]
[11] 杨金鑫, 王海军, 赵永坤, 等. 外泌体的功能及其在临床应用中的研究进展[J]. 中国畜牧兽医, 2018, 45(12): 3608-3613.
[12] Junttila, M.R. and de Sauvage, F.J. (2013) Influence of Tumour Micro-Environment Heterogeneity on Therapeutic Response. Nature, 501, 346-354. [Google Scholar] [CrossRef] [PubMed]
[13] Kanada, M., Bachmann, M.H. and Contag, C.H. (2016) Signaling by Ex-tracellular Vesicles Advances Cancer Hallmarks. Trends Cancer, 2, 84-94. [Google Scholar] [CrossRef] [PubMed]
[14] 余明桔, 王婷, 张焜和. 外泌体在胃癌发生发展中作用的研究进展[J]. 中国肿瘤生物治疗杂志, 2018, 25(11): 1154-1158.
[15] Xu, G., Zhang, B., Ye, J., et al. (2019) Exosomal miRNA-139 in Cancer-Associated Fibroblasts Inhibits Gastric Cancer Progression by Repressing MMP11 Expression. International Journal of Biological Sciences, 15, 2320-2329. [Google Scholar] [CrossRef] [PubMed]
[16] Lin, M., Zhou, C., He, S., et al. (2019) The Research Advances of Exo-somes in Esophageal Cancer. Biomarkers in Medicine, 13, 685-695. [Google Scholar] [CrossRef] [PubMed]
[17] Tian, L., Yang, L., Zheng, W., et al. (2020) RNA Sequencing of Ex-osomes Revealed Differentially Expressed Long Noncoding RNAs in Early-Stage Esophageal Squamous Cell Carcinoma and Benign Esophagitis. Epigenomics, 12, 525-541. [Google Scholar] [CrossRef] [PubMed]
[18] Li, Z., Qin, X., Bian, W., et al. (2019) Exosomal lncRNA ZFAS1 Regulates Esophageal Squamous Cell Carcinoma Cell Proliferation, Invasion, Migration and Apoptosis via microRNA-124/STAT3 Axis. Journal of Experimental & Clinical Cancer Re-search: CR, 38, Article No. 477. [Google Scholar] [CrossRef] [PubMed]
[19] Liu, M.X., Liao, J., Xie, M., et al. (2018) miR-93-5p Transferred by Exosomes Promotes the Proliferation of Esophageal Cancer Cells via Intercellular Communication by Targeting PTEN. Biomedical and Environmental Sciences: BES, 31, 171-185.
[20] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[21] 冯世军, 饶钟茗, 韩冰, 郭伟. 血清外泌体miR-338在老年食管癌中表达及诊断价值[J]. 中国老年学杂志, 2022, 42(1): 30-33.
[22] Su, L.L., Chang, X.J., Zhou, H.D., et al. (2019) Ex-osomes in Esophageal Cancer: A Review on Tumorigenesis, Diagnosis and Therapeutic Potential. World Journal of Clinical Cases, 7, 908-916. [Google Scholar] [CrossRef] [PubMed]
[23] 张筱东, 谢星星, 李佳, 朱帅. 血清外泌体miR-221和miR-378水平检测在胃癌诊断中的应用研究[J]. 现代检验医学杂志, 2020, 35(6): 52-55.
[24] Lin, L.Y., Yang, L., Zeng, Q., et al. (2018) Tumor-Originated Exosomal lncUEGC1 as a Circulating Biomarker for Ear-ly-Stage Gastric Cancer. Molecular Cancer, 17, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[25] Loei, H., Tan, H.T., Lim, T.K., et al. (2012) Mining the Gastric Cancer Secretome: Identification of GRN as a Potential Diagnostic Marker for Early Gastric Cancer. Journal of Proteome Research, 11, 1759-1772. [Google Scholar] [CrossRef] [PubMed]
[26] Zheng, P., Luo, Q., Wang, W., et al. (2018) Tumor-Associated Macro-phages-Derived Exosomes Promote the Migration of Gastric Cancer Cells by Transfer of Functional Apolipoprotein E. Cell Death & Disease, 9, Article No. 434. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, H., Wang, Y., Bai, M., et al. (2018) Exosomes Serve as Nanoparticles to Suppress Tumor Growth and Angiogenesis in Gastric Cancer by Delivering Hepatocyte Growth Factor siRNA. Cancer Science, 109, 629-641. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, F., Bu, Z. and Zhao, F. (2018) Increased T-Helper 17 Cell Differentia-tion Mediated by Exosome-Mediated MicroRNA-451 Redistribution in Gastric Cancer Infiltrated T Cells. Cancer Science, 109, 65-73. [Google Scholar] [CrossRef] [PubMed]
[29] Srinivas, L. and Kgk, D. (2019) Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer. Critical Reviews in Oncogenesis, 24, 179-190. [Google Scholar] [CrossRef
[30] Melo, S.A., Luecke, L.B., Kahlert, C., et al. (2015) Glypican-1 Identifies Cancer Exosomes and Detects Early Pancreatic Cancer. Nature, 523, 177-182. [Google Scholar] [CrossRef] [PubMed]
[31] Shao, H., Zhang, Y., Yan, J., et al. (2021) Upregulated Mi-croRNA-483-3p Is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Bi-omarker in PDAC. OncoTargets and Therapy, 14, 2163- 2175. [Google Scholar] [CrossRef
[32] Cao, S.Q., Zheng, H., Sun, B.C., et al. (2019) Long Non-Coding RNA Highly Up-Regulated in Liver Cancer Promotes Exo-some Secretion. World Journal of Gastroenterology, 25, 5283-5299. [Google Scholar] [CrossRef] [PubMed]
[33] Hu, C., Chen, M., Jiang, R., et al. (2018) Exosome-Related Tumor Microenvironment. Journal of Cancer, 9, 3084- 3092. [Google Scholar] [CrossRef] [PubMed]
[34] Huang, J.Y., Zhang, K., Chen, D.Q., et al. (2015) MicroRNA-451: Epithelial-Mesenchymal Transition Inhibitor and Prognostic Biomarker of Hepatocelluar Carcinoma. Oncotarget, 6, 18613-18630. [Google Scholar] [CrossRef] [PubMed]
[35] Li, S., Yao, J., Xie, M., et al. (2018) Exosomal miRNAs in Hepato-cellular Carcinoma Development and Clinical Responses. Journal of Hematology & Oncology, 11, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, J., Fan, L., Yu, H., et al. (2019) Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-Regulate Programmed Death Ligand 1 Ex-pression in Macrophages. Hepatology (Baltimore, Md.), 70, 241-258. [Google Scholar] [CrossRef] [PubMed]
[37] Yu, Y., Min, Z., et al. (2019) Hypoxia-Induced Exosomes Promote Hepatocellular Carcinoma Proliferation and Metastasis via miR-1273f Transfer. Experimental Cell Research, 385, Article ID: 111649. [Google Scholar] [CrossRef] [PubMed]
[38] Chuammitri, P., Vannamahaxay, S., Sornpet, B., Pringproa, K. and Patchanee, P. (2020) Detection and Characterization of microRNA Expression Profiling and Its Target Genes in Re-sponse to Canine Parvovirus in Crandell Reese Feline Kidney Cells. PeerJ, 8, e8522. [Google Scholar] [CrossRef] [PubMed]
[39] Zhang, Z., Xing, T. and Chen, Y. (2018) Exosome-Mediated miR-200b Promotes Colorectal Cancer Proliferation upon TGF-β1 Exposure. Biomedicine & Pharmacotherapy, 106, 1135-1143. [Google Scholar] [CrossRef] [PubMed]
[40] Chen, Y., Xie, Y., Xu, L., et al. (2017) Protein Content and Functional Characteristics of Serum-Purified Exosomes from Patients with Colorectal Cancer Revealed by Quantitative Proteomics. International Journal of Cancer, 140, 900-913. [Google Scholar] [CrossRef] [PubMed]
[41] Lan, J., Sun, L., Xu, F., et al. (2019) M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer. Cancer Research, 79, 146-158. [Google Scholar] [CrossRef
[42] Gao, T., Liu, X., He, B., et al. (2018) Exosomal lncRNA 91H Is Associated with Poor Development in Colorectal Cancer by Modifying HNRNPK Expression. Cancer Cell International, 18, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
[43] 李航, 帖晓静, 朱鸿波, 黄昊. 血清外泌体miRNA对结直肠癌患者免疫调控及预后价值的研究[J]. 现代肿瘤医学, 2022, 30(8): 1443-1448.
[44] 王晓昱, 徐兴祥. 外泌体在肿瘤中的研究进展[J]. 国际呼吸杂志, 2019, 39(8): 594-598.
[45] Alfonsi, R., Grassi, L. and Signore, M. (2018) The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation. International Journal of Molecular Sci-ences, 19, Article No. 1183. [Google Scholar] [CrossRef] [PubMed]
[46] Lafitte, M. and Lecointre, C. (2019) Roles of Exosomes in Metastatic Colon Cancer. American Journal of Physiology. Cell Physiology, 317, C869-C880. [Google Scholar] [CrossRef] [PubMed]